|January 12th, 2011||Quantifi Releases Version 10.0 to Satisfy OTC Market Demand for Counterparty Risk Management and Regulatory Compliance
- Quantifi Version 10.0 provides significantly broader asset coverage including Hybrids
- Delivers enhanced scalability, groundbreaking performance and key improvements in complex OTC valuation and Counterparty Risk Management
|November 22nd, 2010||Waiver of Mandatory Clearing Requirements for Certain OTC Derivatives Would Reduce Risk, says ISDA
The waiver of mandatory clearing requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act for certain OTC derivatives transactions would reduce risk in the financial system and help to achieve the risk-reduction goals of the Act, the International Swaps and Derivatives Association, Inc. (ISDA) said today.
|October 29th, 2010||Hedge Funds: Risk Reporting to Meet Demands of Regulators and Investors
Investors require in-depth risk reporting and lower fees whilst regulators are soon to introduce their own set of reporting requirements that hedge funds must comply with. In a Q&A, Sophis' Eric Bernstein explains how hedge funds improve the transparency in risk reports whilst managing operational costs efficiently in an ASP solution.
Q. How has risk reporting changed post-financial crisis? What are investors demanding?
|October 25th, 2010||Global OTC Derivative Reform Rules: A Glimpse of What’s to Come
Reval's ceo and co-founder Jiro Okochi shares insight on how regulatory reform is progressing based on his participation in the GMAC meeting earlier this month. Read on for details on rules affecting end-users and collaboration between Europe and the US in defining those new regulatory rules
|October 20th, 2010||Global Regulatory Overhaul is Pushing for Greater Transparency in OTC Instruments, Says TABB Group
New Research Report Examines the Changing OTC Valuations Industry; OTC Valuation Spending Projected to Grow at an 11% CAGR through 2013
|October 18th, 2010||Upcoming Central Clearing for OTC Derivatives Webinar; Nov 16th
Register for this Complimentary Webinar November 16, 2010
Central Clearing OTC Derivatives in a New Regulatory Environment: Understanding use of CCP Clearing under Dodd-Frank Legislation
|October 4th, 2010||Basel III Misses Opportunity to Break Down the Silo Culture in Banking
Algorithmics questions the missing link between capital and liquidity
|September 21st, 2010||The Dodd-Frank Act's Title VII in Brief
The Dodd-Frank Wall Street Reform and Consumer Protection Act will transform the derivatives industry. In a Q&A, Sean Owens of Woodbine Associates offers the key elements included in Title VII of the Dodd-Frank Act.
Q. What are the major provisions included in the Dodd-Frank Act?
|September 15th, 2010||European Commission Proposals for Regulation of OTC Derivatives - News & Comments Roundup
Today the European Commission published it's proposals for measures on derivatives, credit default swaps (CDS) and short selling to restore confidence in financial markets. Below are links to the proposal briefs and comments released by ISDA, AIMA and members of the Economic & Monetary Affairs Committee.
I'll continue to add links and more news comes in. You may also add your favorite links below in the comments section.
|September 15th, 2010||ISDA Comments on Proposals Released by the European Commission Relating to Markets Infrastructure and Aspects of CDS
The International Swaps and Derivatives Association, Inc. (ISDA) today made the following statement regarding the proposals by the European Commission on markets infrastructure and aspects of CDS:
The European Commission’s proposals on market infrastructure for OTC derivatives are of great importance to the health of our economies and stability of the financial system.
- Opinion & Analysis
- Careers & People
- Events & Podcasts
- About Us